【レポートの概要（一部）】
1. Introduction to Cancer Vaacines
2. Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism
3. Adjuvants Therapy for Cancer Vaccines
4. Global Cancer Vaccines Market Overview
4.1 Current Market Scenario
4.2 Global Cancer Vaccine Drug Pipeline by Indication
5. Emergence of Personalized Cancer Vaccines
6. Public HPV Cancer Vaccination Program
7. Global Cancer Vaccines Market Dynamics
7.1 Favorable Market Parameters
7.1.1 Pottential Demand for Cancer Vaccines
7.1.2 Public Cancer Vaccination Program
7.1.3 Advancements in Development Technology
7.1.4 Personalized Cancer Vaccines
7.1.5 Myriad of Demographs for Cancer Vaccine Development
7.2 Commercialization Challenges
8. Global Cancer Vaccine Market Future Outlook
9. Bladder Cancer Vaccine Clinical Pipeline Insight by Company & Phase
9.1 Phase-II
10. Blood Cancer Vaccine Clinical Pipeline Insight by Company & Phase
10.1 Research till Preregistration
11. Brain Cancer Vaccine Clinical Pipeline Insight by Company & Phase
11.1 Preclinical Till Phase-III
12. Breast Cancer Vaccine Clinical Pipeline Insight by Company & Phase
12.1 Preclinical till Phase-III
13. Cancer Vaccine Clinical Pipeline Insight by Company & Phase
13.1 Research till Phase-II
14. Cervical Cancer Vaccine Clinical Pipeline Insight by Company & Phase
14.1 Phase-II
15. Colorectal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
15.1 Preclinical till Preregistration
16. Head and Neck Cancer Vaccine Clinical Pipeline Insight by Company & Phase
16.1 Preclinical till Phase-I/II
17. Liver Cancer Vaccine Clinical Pipeline Insight by Company & Phase
17.1 Phase-I till Phase-II
18. Lung Cancer Vaccine Clinical Pipeline Insight by Company & Phase
18.1 Preclinical till Phase-III
19. Oesophageal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
19.1 Phase-III
20. Ovarian Cancer Vaccine Clinical Pipeline Insight by Company & Phase
20.1 Preclinical till Phase-III
21. Pancreatic Cancer Vaccine Clinical Pipeline Insight by Company & Phase
21.1 Reseach till Phase-III
22. Prostate Cancer Vaccine Clinical Pipeline Insight by Company & Phase
22.1 Preclinical till Phase-III
23. Renal Cancer Vaccine Clinical Pipeline Insight by Company & Phase
23.1 Phase-I till Phase-III
24. Sarcoma Vaccine Clinical Pipeline Insight by Company & Phase
24.1 Phase-II
25. Skin Cancer Vaccine Clinical Pipeline Insight by Company & Phase
25.1 Preclinical till Phase-III
26. Solid Tumours Vaccine Clinical Pipeline Insight by Company & Phase
26.1 Preclinical till Phase-II
27. Multiple Cancer Vaccine Clinical Pipeline Insight by Company & Phase
27.1 Preclinical till Phase-III
28. Marketed Cancer Vaccine Clinical Insight by Company & Indication
28.1 Bladder Cancer
28.1.1 BCG Bladder Cancer Vaccine (Immucyst® & TheraCys®)
28.1.2 Bladder Cancer Vaccine (PACIS®)
28.1.3 Bladder Cancer Vaccine – Organon Teknika
28.2 Cervical Cancer
28.2.1 Human Papillomavirus Vaccine Recombinant Bivalent (Cervarix®)
28.3 Lung Cancer
28.3.1 BV NSCLC 001
28.3.2 Cadi 05 (Immuvac® & Mycidac-C™)
28.3.3 Racotumomab (Vaxira®)
28.4 Pancreatic Cancer
28.4.1 Tertomotide (LucaVax)
28.5 Prostate Cancer
28.5.1 Sipuleucel-T (Provenge®)
28.6 Renal Cancer
28.6.1 Renal Cancer Vaccine (Reniale®)
28.6.2 Vitespen (Oncophage®)
28.7 Skin Cancer
28.7.1 Melanoma Vaccine (MVax®)
28.7.2 Melanoma Vaccine (Melacine®)
28.8 Multiple Cancer
28.8.1 Human Papillomavirus Vaccine 9-Valent (V503) (GARDASIL®9)
28.8.2 Human Papillomavirus Vaccine Quadrivalent (Gardasil® & Silgard®)
29. Discontinued & Suspended Cancer Vaccine Drug Clinical Pipeline Insight
29.1 No Development Reported
29.2 Discontinued
29.3 Suspended
30. FDA Regulatory Framework for Cancer Vaccines Development & Marketing
30.1 Considerations for both Early and Late Phase Clinical Trials
30.1.1 Patient Population
30.1.2 Monitoring the Immune Response
30.1.3 Biomarkers as Evidence Of Efficacy
30.1.4 Adjuvants Used To Stimulate Immune Response
30.1.5 Multi-Antigen Vaccines
30.1.6 Disease Progression/Recurrence Immediately Or Shortly After The Initial Administration Of Cancer Vaccines
30.1.7 Concomitant and Subsequent Therapies
30.2 Considerations for Early Phase Clinical Trials
30.2.1 Starting Dose and Dosing Schedule
30.2.2 Booster and Maintenance Therapy
30.2.3 Dose Escalation
30.2.4 Single-Arm versus Randomized Phase 2 Trials In Early Development
30.3 Considerations for Late Phase Clinical Trials
30.3.1 Safety Profile from Early Phase Clinical Trials
30.3.2 Endpoints
30.3.3 Statistical Issues
30.3.4 Control Issues
30.3.5 Delayed Vaccine Effect
30.3.6 Autologous Vaccine Trials
30.3.7 Accelerated Approval Regulations
31. Competitive Landscape: Business Overview & Product Pipeline
31.1 Advaxis
31.2 AVAX Technologies
31.3 Celldex Therapeutics
31.4 Dendreon Corporation
31.5 Galena Biopharma
31.6 GlaxoSmithKline
31.7 ImmunoCellular Therapeutics
31.8 ImmunoGen
31.9 Inovio Pharmaceuticals
31.10 KAEL-GemVax
31.11 Liponova
31.12 MedImmune
31.13 Merck
31.14 NeoStem Oncology
31.15 NewLink Genetics
31.16 Northwest Biotherapeutics
31.17 Novartis
31.18 Peregrine Pharmaceuticals
31.19 Recombio
31.20 Roche
31.21 Sanofi
31.22 Seattle Genetics
31.23 Valeant Pharmaceuticals
【レポート販売概要】
■ タイトル：がんワクチンの世界市場及び治験インサイト■ 英文：Global Cancer Vaccine Market & Clinical Trial Insight
■ 発行日：42248
■ 調査会社：KuicK Research
■ 商品コード：KUIK51102
■ 調査対象地域：グローバル
- クラウドストレージサービスの世界市場予測・分析2020-2024Global Cloud Storage Services Market: About this market Technavio’s cloud storage services market analysis considers sales from both large enterprises and SMEs end-users. Our study also finds the sales of cloud storage services in APAC, Europe, MEA, North America, and South America. In 2018, the large enterprise's segment had a significant market share, and this trend is expected to continue over …
- HIV感染症：企業と競争環境PharmaPoint: HIV - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: HIV - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HIV Market. The report identifies and analyses the key companies shaping and driving the global HIV market. The report provides insight …
- HIPPS（高度圧力保護システム）の世界市場2016-2020About High-Integrity Pressure Protection System HIPPS are a series of components, specifically engineered to isolate the source of hazardous high pressure instead of relieving excess flow in case of an over-pressure event. These are independent and reliable safety systems designed with high integrity as per ANSI/ISA and IEC standards to equal or exceed the safety performance of conventional safety …
- グリッドスケール電力貯蔵バッテリー（GSB）の世界市場Visiongain’s comprehensive new 227 page report reveals that CAPEX invested in grid scale battery (GSB) storage technologies will reach $717.2m in 2015, with rapid growth anticipated over the next ten years. Market scope: The grid scale battery (GSB) storage market is largely an emerging one, especially when compared with other energy storage systems such as the well-established pumped hydro storag …
- プロトン交換膜燃料電池（PEMFC）の世界市場About PEMFC PEMFC are devices that generate electricity through an electrochemical process involving oxidation of electrolytes placed between the anode and the cathode. Fuel cells are generally categorized based on the type of electrolyte used. PEMFC use an acidic water-based polymer membrane with platinum-based electrodes. It operates at low temperatures and caters effectively to dynamic power re …
- 世界のグラフィック・プロセッサー市場動向（2012-2016）TechNavio's analysts forecast the Global Graphic Processor market to grow at a CAGR of 3.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for higher memory graphic cards. The Global Graphic Processor market has also been witnessing the increase in R&D spending by vendors. However, the high dependency on third party semiconducto …
- Saudi ArabiaのSodium Triphosphate (Sodium Tripolyphosphate)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for sodium triphosphate (sodium tripolyphosphate). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on sodium triphosphate (sodium tripolyphosphate) export/imp …
- スタンドアップパドルボード（SUP）の世界市場2016-2020：パドルボード、パドル、パドルボードアクセサリAbout Stand-Up Paddle BoardThe soft adventure sporting goods market, especially SUP board, holds great growth potential globally. It is mainly driven by the growing interest of consumers in outdoor recreational activities and the availability of a wide range of SUP boards. In addition, the tourism industry has also encapsulated water sports among the various activities available for domestic and i …
- 世界の髄核置換装置市場：医療機器パイプライン分析2016Nucleus Replacement - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview of Nucleus Replacement currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development …
- 自動給餌システムの世界市場予測（～2023年）“The automated feeding systems market is projected to grow at a CAGR of 7.6%.”The automated feeding systems market is estimated to account for nearly USD 5.1 billion in 2018 and is projected to grow at a CAGR of 7.6%, to reach nearly USD 7.4 billion by 2023. The market is driven by the increasing preference of farm owners to automate processes for reducing operating costs and losses associated wit …
- 油田用トラベリングブロックの世界市場2019-2023Global Oilfield Traveling Blocks Market: About this market Technavio’s oilfield traveling blocks market analysis considers sales from the onshore and offshore segments. Our analysis also considers the sales of oilfield traveling blocks in APAC, Europe, MEA, North America, and South America. In 2018, the onshore segment held the highest market share, which is expected to remain prevalent over the f …
- 世界のLCDテレビ用コアチップ市場動向The development pace of video processor is slowing down as the LCD TV (Liquid Crystal Display Television) industry approaches maturity. Therefore, the LCD TV core chip industry has been pinning high hopes on emerging LCD products such as smart TV and 4K2K TV. The rise of smart TV also has enticed other areas of chipmakers to set foot into this sector, leading to an increasingly intense competition …
- 神経血管用デバイス/インターベンショナル神経医学の世界市場：塞栓形成、頸動脈ステント留置術、バルーン血管形成術、NeurothrombectomyThe global neurovascular devices/interventional neurology market is poised to reach ~$2,370.4 million by 2020, growing at a CAGR of 8.4% from 2015 to 2020. North America is expected to hold the largest share of 47.3% of the global market in 2015. Market growth is being propelled by growing target patient population, technological advancements in the field of interventional neurosurgeries, favorabl …
- データセンター資産管理の世界市場予測：ソフトウェア、サービス、ハードウェアThe increased overhead costs and complexities in managing data centers have given way to the adoption of data center asset management solutions, thereby aiding companies in cutting down their time, Operational Expenditure (OPEX), and Capital Expenditure (CAPEX), and empowering them with better inventory management and resource planning. The data center asset management market is estimated to grow …
- 生物剤検知システムの世界市場2014-2018About Bio-detection Bio-detection has emerged as a solution to the public and governments. With an increase in bio-terrorism, the occurrence of illness and deaths is very frequent. This event is caused by the airborne chemicals or pathogens that are released by a terrorist or a group of people or even by an individual for a motive. These pathogens can be detected by a system called bio-detection, …
